The average life expectancy for peritoneal mesothelioma can vary significantly based on various factors such as the stage at diagnosis, treatment received, overall health of the patient, and other individual factors.
Historically, peritoneal mesothelioma had a poorer prognosis compared to other forms of mesothelioma. However, advancements in treatment options, including surgery, chemotherapy, and emerging therapies like heated intraperitoneal chemotherapy (HIPEC), have improved survival rates for some patients.
On average, without treatment, the life expectancy for peritoneal mesothelioma might be around 6 to 12 months after diagnosis. However, with a multimodal treatment approach that could include surgery and chemotherapy, some patients have seen an extended life expectancy ranging from 1 to 5 years or more, depending on individual circumstances and response to treatment.
It’s essential to consult with medical professionals who specialize in mesothelioma to get a clearer understanding of the specific prognosis and available treatment options based on an individual’s case. Each person’s situation is unique, and various factors play a role in determining life expectancy and treatment outcomes.